Coronavirus envelope protein: current knowledge
Explore this paper's citation graph
Summary
This review aims to establish the current knowledge on CoV E by highlighting the recent progress that has been made and comparing it to previous knowledge, and compares E to other viral proteins of a similar nature to speculate the relevance of these new findings.
- Type
- review
- Published
- 2019-05-27
- Cited by
- 1,786
- References
- 297
- Access
- Open access
- OpenAlex
- https://openalex.org/W2947642275
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:167209083
Keywords
Biology, Enzootic, Coronavirus, Viral pathogenesis, Viral life cycle
References
- Signal integration in the endoplasmic reticulum unfolded protein response
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- Tracing the SARS-coronavirus.
- Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions.
- Tmbase-A database of membrane spanning protein segments
- Viroporin Activity of the Foot-and-Mouth Disease Virus Non-Structural 2B Protein
- The E Protein Is a Multifunctional Membrane Protein of SARS-CoV
- Coronaviruses: An Overview of Their Replication and Pathogenesis
- Animal models for SARS and MERS coronaviruses
- Regulation of protein-protein interactions using stapled peptides
- Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
- Molecular Interactions in the Assembly of Coronaviruses
- Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
- Local protein structure prediction using discriminative models
- Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus
- The molecular basis of the specific anti‐influenza action of amantadine.
- The Molecular Biology of Coronaviruses
- The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer
- Determination of the distance between the oligosaccharyltransferase active site and the endoplasmic reticulum membrane.
- The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release
Cited by
- Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach
- Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
- Isolation and Characterisation of Alongshan Virus in Russia
- Specific Detection of Bovine Coronavirus N Protein with TaqMan Probe qRT-PCR
- Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
- Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus
- Genomic variance of the 2019‐nCoV coronavirus
- Treatment Strategies for Reducing Damages to Lungs In Patients with Coronavirus and Other Infections
- Revisiting the dangers of the coronavirus in the ophthalmology practice
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
- Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
- Potential interventions for novel coronavirus in China: A systematic review
- Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach
- Functional pangenome analysis suggests inhibition of the protein E as a readily available therapy for COVID-2019
- Dewetting Antibodies Against Viroporins Might Contribute to Decrease 2019-Ncov Infection Spread
- Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study
- Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
- The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
- Coronavirus Disease 2019–COVID-19
- Preventive, Mitigating and Treatment Strategies for Containing or Ending The COVID-19 Pandemic (a first update)
Related papers
- Middle East Respiratory Syndrome (MERS) - Facts
- Middle East Respiratory Syndrome: Knowledge to Date*
- Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013
- Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
- Alternative Screening Approaches for Discovery of Middle East Respiratory Syndrome Coronavirus Inhibitors
- Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy